www.miragenews.com ·
indonesia sets new halal rules for medicines 1672395
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedIndonesia's new halal certification rules for medicines and medical devices create a regulatory compliance cost for pharmaceutical and medical device companies exporting to Indonesia. The mechanism is regulatory: companies must adjust manufacturing, documentation, and sourcing (especially animal-derived materials) to meet halal standards. This affects both domestic and foreign producers, with phased implementation from 2026. The impact is Indonesia-specific but may influence other Muslim-majority markets. Winners could include halal-certified producers; losers include non-certified exporters facing market access barriers. The commercial mechanism is concrete but the magnitude is uncertain until implementation details are clarified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Indonesia's Halal Product Assurance framework (Law No. 33/2014) now requires halal certification for medicines and medical devices.
- Regulations based on Presidential Regulation No. 6/2023 and Minister of Health Regulation No. 3/2024.
- Phased implementation starting in 2026, varying by product type and risk classification.
- BPJPH (Halal Product Assurance Organising Agency) will oversee certifications.
- Australian Government is engaging with Indonesia to assist exporters.
Indonesia-specific regulatory change has limited short-term impact on broader EM markets.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- EM_MARKETSmid
- EM_MARKETSshort
- MEDICAL_DEVICESmid
- MEDICAL_DEVICESshort
- PHARMA_BIOTECHmid
- PHARMA_BIOTECHshort